AULT MILTON C III 13D and 13G filings for Alzamend Neuro, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-07 9:53 pm Sale | 2025-10-03 | 13D | Alzamend Neuro, Inc. ALZN | AULT MILTON C III | 166,909 4.400% | -139,412 (-45.51%) | Filing |
| 2025-10-03 9:37 pm Sale | 2025-10-01 | 13D | Alzamend Neuro, Inc. ALZN | AULT MILTON C III | 306,321 8.000% | -123,366 (-28.71%) | Filing |
| 2025-09-30 8:51 pm Sale | 2025-09-26 | 13D | Alzamend Neuro, Inc. ALZN | AULT MILTON C III | 429,687 11.200% | -79,628 (-15.63%) | Filing |
| 2025-09-25 9:37 pm Sale | 2025-09-23 | 13D | Alzamend Neuro, Inc. ALZN | AULT MILTON C III | 509,315 13.300% | -97,006 (-16.00%) | Filing |
| 2025-09-23 4:30 pm Sale | 2025-09-19 | 13D | Alzamend Neuro, Inc. ALZN | AULT MILTON C III | 606,321 15.900% | -100,001 (-14.16%) | Filing |
| 2025-08-01 8:52 pm Purchase | 2025-07-23 | 13D | Alzamend Neuro, Inc. ALZN | AULT MILTON C III | 706,322 18.500% | 706,322 (New Position) | Filing |